GSK, Pfizer and RSV
This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
The change was prompted by postmarketing observational studies that suggest an increased risk of GBS within 42 days of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results